Elotuzumab
Daratumumab (MM)
Carfilzomib
Ixazomib
Multiple Myeloma Research Foundation (MMRF)
National Cancer Institute (NCI) - Supported Cancer Clinical Trials
NCCN Virtual Reimbursement Resource Room
NCCN Guidelines for Patients: Multiple Myeloma